A stronger surgical seal

| Print |  Email
Articles - April 2011
Tuesday, March 22, 2011
0411_NextA product made from naturally occurring human fibrinogen (a soluble plasma glycoprotein), Gamma Prime Fibrinogen, is under development as a high-strength surgical sealant that resists being broken down by the body and would have the ability to withstand higher blood pressure in vascular wounds. “With a lot of sealants used today the body’s natural enzymes break them down,” says David Eastman, CEO of Gamma Therapeutics, the Portland-based biotech company that is developing the sealant. Built on research by Dr. David Farrell, an OHSU professor and founder of Gamma Therapeutics, the sealant can be sprayed or dripped onto a wound, and once dissolved with water the clotting process to form the seal begins. Farrell says the sealant would be most useful where there is significant tissue damage, such as from trauma surgeries and hip or knee replacements. A patent is pending for the Gamma Seal while grant requests are being made to the National Institutes of Health and the Department of Defense.
MAX GELBER
 

More Articles

Kill the Meeting

November/December 2014
Wednesday, October 22, 2014
BY AMY MILSHTEIN

Meetings get a bad rap. A few local companies make them count.


Read more...

Free Falling

Contributed Blogs
Thursday, December 18, 2014
121714-oilprice-thumbBY JASON NORRIS | OB CONTRIBUTOR

The implosion of the energy complex: The best thing for low oil prices is low oil prices.


Read more...

A Complex Portrait: Immigration, Jobs and the Economy

November/December 2014
Wednesday, October 22, 2014
BY JOE ROJAS-BURKE & KIM MOORE

Oregon Business reports on the visa squeeze, the skills gap and foreign-born residents who are revitalizing rural Oregon.


Read more...

Healthcare pullback

News
Thursday, November 20, 2014
112014-boehnercare-thumbBY JASON NORRIS | OB CONTRIBUTOR

Each month for Oregon Business, we assess factors that are shaping current capital market activity—and what they mean to investors. Here we take a look at two major developments regarding possible rollbacks of the Affordable Care Act (ACA).


Read more...

Shifting Ground

November/December 2014
Wednesday, October 22, 2014
BY JOE ROJAS-BURKE

Bans on genetically modified crops create uncertainty for farmers.


Read more...

Election Season

November/December 2014
Wednesday, October 22, 2014

We didn’t intend this issue to have an election season theme. But politics has a way of seeping into the cracks and fissures.


Read more...

What I'm Reading

November/December 2014
Wednesday, October 22, 2014

Peter Lizotte at ACME Business Solutions and Roger Busse at Pacific Continental Bank share their favorite reads.


Read more...
Oregon Business magazinetitle-sponsored-links-02
SPONSORED LINKS